WebJul 24, 2015 · Key clinical point: Aromatase inhibitors (AIs) and bisphosphonates help prevent recurrence of early-stage breast cancer in postmenopausal women. Major finding: Recurrence of estrogen receptor–positive breast cancer was about 30% lower for AIs compared with tamoxifen during years 0-1 and 2-4 (P WebBisphosphonates reduce the risk of fracture and bone pain [14] in people with breast, [15] lung, [16] and other metastatic cancers as well as in people with multiple myeloma. [17] In breast cancer there is mixed evidence regarding …
Denosumab Compared With Zoledronic Acid for the Treatment of …
WebJul 27, 2024 · Aredia (chemical name: pamidronate) is another bisphosphonate, but it is not used to treat osteoporosis. Aredia is used to reduce bone complications and bone … WebApr 12, 2024 · This article focuses on the role of osteoclast inhibitors in breast cancer and preventing thinning of the bone. Read the article to know more. New Same-day primary and urgent care Consult Doctor; Physician Directory; More . Ask a Doctor Online. Chat with a Doctor. Phone a Doctor. Video Consultation. Medical Second Opinion NEW. dw subs menu
Bisphosphonate Toxicity - StatPearls - NCBI Bookshelf
WebIn this context, several recent observational studies have investigated a chemoprevention role for oral bisphosphonates in decreasing risk for breast cancer. This review will aim … WebJan 18, 2024 · Adjuvant bisphosphonate therapy should be discussed with all postmenopausal patients (natural or therapy-induced) with primary breast cancer, irrespective of hormone receptor status and human epidermal growth factor receptor 2 status, who are candidates to receive adjuvant systemic therapy. Webradiotherapy. hormonal therapy (also called endocrine therapy) targeted cancer drugs. bone strengthening drugs (bisphosphonates) You might have a combination of these treatments, depending on your situation. Your doctor will take many different factors into account when deciding which treatment is best for you. dw-suggestions.dreamwidth.org editing